Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial

Mayer, Katharina; Hein-Rothweiler, Ralph; Schupke, Stefanie; Janisch, Marion; Bernlochner, Isabell; Ndrepepa, Gjin; Sibbing, Dirk; Gori, Tommaso; Borst, Oliver; Holdenrieder, Stefan; Kupka, Danny; Petzold, Tobias; Bradaric, Christian; Okrojek, Rainer; Leistner, David M.; Trippel, Tobias D.; Muenzel, Thomas; Landmesser, Ulf; Pieske, Burkert; Zeiher, Andreas M.; Gawaz, Meinrad P.; Hapfelmeier, Alexander; Laugwitz, Karl-Ludwig; Schunkert, Heribert; Kastrati, Adnan; Massberg, Steffen

Efficacy and Safety of Revacept, a Novel Lesion-Directed Competitive Antagonist to Platelet Glycoprotein VI, in Patients Undergoing Elective Percutaneous Coronary Intervention for Stable Ischemic Heart Disease The Randomized, Double-blind, Placebo-Controlled ISAR-PLASTER Phase 2 Trial

Autor(en):

Mayer, Katharina; Hein-Rothweiler, Ralph; Schupke, Stefanie; Janisch, Marion; Bernlochner, Isabell; Ndrepepa, Gjin; Sibbing, Dirk; Gori, Tommaso; Borst, Oliver; Holdenrieder, Stefan; Kupka, Danny; Petzold, Tobias; Bradaric, Christian; Okrojek, Rainer; Leistner, David M.; Trippel, Tobias D.; Muenzel, Thomas; Landmesser, Ulf; Pieske, Burkert; Zeiher, Andreas M.; Gawaz, Meinrad P.; Hapfelmeier, Alexander; Laugwitz, Karl-Ludwig; Schunkert, Heribert; Kastrati, Adnan; Massberg, Steffen

Tübinger Autor(en):

Borst, Oliver
Gawaz, Meinrad Paul

Erschienen in:

Jama Cardiology (2021), Bd. 6, H. 7, S. 753-761

Verlagsangabe:

Chicago

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1001/jamacardio.2021.0475

ISSN:

2380-6583